Weizhong Cai,Prakash Narayan,Bijoy Panicker,David E. Smith
申请号:
US15440398
公开号:
US20180009793A1
申请日:
2017.02.23
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The present invention provides compositions and formulations of compounds having formula (I) and pharmaceutically acceptable derivatives thereof, wherein p, R1, R2 and B are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of injuries, conditions or diseases in which HGF/SF or the activities thereof, or agonists or antagonists thereof have a therapeutically useful role. In addition, methods are provided for treating such diseases or diseases starting at a time after the onset of the injury, condition or disease.